Table 1.
Summary of data from patient records for 5 adult alpacas presented for severe anemia and weight loss
| Case number | Age (y) | PCV%/TP g/La | Anthelmintic treatmentb | Pre-treatment FEC (eggs/g) | Follow-up FEC (eggs/g) | Days to follow-up FEC | FECR |
|---|---|---|---|---|---|---|---|
| 1c | 3 | 4/3.7 | FBZ | 1680 | 815 | 13 | 51% |
| 2 | 2 | 4/4.3 | PP | > 10 000 | 485 | 6 | > 95% |
| 3 | 1 | 10/4.9 | NA | 0 | NA | NA | NA |
| 4 | 2 | 9/5.4 | Levamisole | 1070 | 0 | 7 | 100% |
| 5 | 1 | 7/5.5 | Levamisole | 5 | NA | NA | NA |
NA (not available) — information not recorded; FEC — fecal egg count, FECR — fecal egg count reduction.
a
PCV — packed cell volume (reference range: 27% to 45%); TP — serum total protein (reference range: 51 to 79 g/L).
b
FBZ — fenbendazole 10 mg/kg BW PO; PP — pyrantel pamoate 18 mg/kg BW PO; levamisole — treated by owner on the day of admission with 8 mg/kg BW, PO.
c
Animal 1 had a body condition score of 1 of 5; body condition scores for the other 4 animals were not available in the medical record.